BetterLife Pharma Highlights Advantages of BETR-001 -- a Potent Neuroplastogen

Stock Information for BetterLife Pharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About BetterLife Pharma Inc.

BetterLife Pharma Welcomes Daniel Carcillo as Corporate Advisor
BetterLife Pharma Appoints Doug Drysdale as Corporate Advisor
USPTO Files ISSUE NOTIFICATION for BetterLife's BETR-001 Composition of Matter Patent
BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001
BetterLife Provides Comments on CEO's Share Position Ownership and Recent BCSC Press Release
BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders
BetterLife Announces Debt Settlements
BetterLife Pharma Appoints Corporate Advisor

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.